E Fund (HK) Solactive Biopharma Select Index ETF (03186.HK) Rises 2.24% to HKD 14.600

NewTimeSpace · 2026/09/14 15:27 · By Ruifeng Zhao

As of 15:26 on September 14, E Fund (HK) Solactive Biopharma Select Index ETF (03186.HK) rose 2.24% to HKD 14.600, with a turnover of approximately HKD 23,100 and assets under management of approximately HKD 24.28 million.

Key Highlights:

E Fund (HK) Solactive Biopharma Select Index ETF (03186.HK) is up 2.24% at HKD 14.600.
Turnover is approximately HKD 23,100, with assets under management of approximately HKD 24.28 million.
The ETF tracks the Solactive Biopharma Select Index, focusing on frontier sectors such as innovative drugs, CXO, and biotechnology.

NewTimeSpace News: As of 15:26 on September 14, E Fund (HK) Solactive Biopharma Select Index ETF (03186.HK) stood at HKD 14.600, up 2.24%. The ETF opened at HKD 14.280, with the latest net asset value (NAV) at HKD 14.281, a discount of 0.01%, a 52-week high of HKD 16.950, a 52-week low of HKD 12.710, a turnover of approximately HKD 23,100, and assets under management of approximately HKD 24.28 million.

E Fund (HK) Solactive Biopharma Select Index ETF (03186.HK) tracks the Solactive Biopharma Select Index (Net Total Return), focusing on frontier sectors such as innovative drugs, CXO, and biotechnology.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.

Tags：

E Fund (HK) Solactive Biopharma Select Index ETF 03186.HK ETF